Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Eun Jeoung LeeSeung Min LeeJu Hee OhHye Young KimWaqar Khalid SaeedHyun Sung KimDae Won JunPublished in: Nutrients (2024)
Ticagrelor attenuated NAS and hepatic steatosis in a MASLD mice model by attenuating lipogenesis and inflammation, but not in the CLO group.